Chapter 19 New Therapy for Neuropathic Pain

Alford, 2006, Acute pain management for patients receiving maintenance methadone or buprenorphine therapy, Ann. Intern. Med., 144, 127, 10.7326/0003-4819-144-2-200601170-00010 Arnér, 1988, Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain, Pain, 33, 11, 10.1016/0304-3959(88)90198-4 Bennett, 1988, A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, Pain, 33, 87, 10.1016/0304-3959(88)90209-6 Bian, 1995, Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats, Neuroreport, 6, 1981, 10.1097/00001756-199510010-00007 Chen, 2003, Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats, Anesthesiology, 99, 1409, 10.1097/00000542-200312000-00026 Chen, 2002, Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats, Anesthesiology, 97, 1602, 10.1097/00000542-200212000-00037 Courteix, 1998, Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?, J. Pharmacol. Exp. Ther., 285, 63 Covington, 1998, Anticonvulsants for neuropathic pain and detoxification, Cleve. Clin. J. Med., 65, S121 DeGroot, 1997, The reorganization of mu opioid receptors in the rat dorsal horn following peripheral axotomy, Neurosci. Lett., 233, 113, 10.1016/S0304-3940(97)00642-3 Dworkin, 2003, Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations, Arch. Neurol., 60, 1524, 10.1001/archneur.60.11.1524 Dworkin, 2007, Pharmacologic management of neuropathic pain: Evidence‐based recommendations, Pain, 132, 237, 10.1016/j.pain.2007.08.033 Eisenberg, 2005, Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta‐analysis of randomized controlled trials, JAMA, 293, 3043, 10.1001/jama.293.24.3043 Eisenberg, 2006, Efficacy of mu‐opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials, Eur. J. Pain, 10, 667, 10.1016/j.ejpain.2005.10.007 Gabra, 2005, Hyperalgesia in non‐obese diabetic (NOD) mice: A role for the inducible bradykinin B1 receptor, Eur. J. Pharmacol., 514, 61, 10.1016/j.ejphar.2005.03.018 Gilron, 2003, Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat pawpressure and tail‐flick tests, Anesthesiology, 98, 1288, 10.1097/00000542-200305000-00037 Gorman, 1997, The d‐ and l‐isomers of methadone bind to the non‐competitive site on the N‐methyl d‐aspartate (NMDA) receptor in rat forebrain and spinal cord, Neurosci. Lett., 223, 5, 10.1016/S0304-3940(97)13391-2 Gracely, 1992, Painful neuropathy: Altered central processing maintained dynamically by peripheral input, Pain, 51, 175, 10.1016/0304-3959(92)90259-E Grass, 1996, N‐methyl‐d‐aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat, Acta Physiol. Scand., 158, 269, 10.1046/j.1365-201X.1996.566309000.x Hains, 2004, Altered sodium channel expression in second‐order spinal sensory neurons contributes to pain after peripheral nerve injury, J. Neurosci., 24, 4832, 10.1523/JNEUROSCI.0300-04.2004 Honore, 2000, Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons, Neuroscience, 98, 585, 10.1016/S0306-4522(00)00110-X Hylden, 1991, Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms, Eur. J. Pharmacol., 194, 135, 10.1016/0014-2999(91)90097-A Kajander, 1990, Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy, Peptides, 11, 719, 10.1016/0196-9781(90)90187-A Kalso, 2004, Opioids in chronic non‐cancer pain: Systematic review of efficacy and safety, Pain, 112, 372, 10.1016/j.pain.2004.09.019 Kim, 1992, An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat, Pain, 50, 355, 10.1016/0304-3959(92)90041-9 Kim, 1996, Inhibition by MK‐801 of morphineinduced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice, Pharmacol. Biochem. Behav., 55, 11, 10.1016/0091-3057(96)00078-0 Lee, 1995, Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model, Neurosci. Lett., 199, 111, 10.1016/0304-3940(95)12034-2 Lemberg, 2006, Antinociception by spinal and systemic oxycodone: Why does the route make a difference? In vitro and in vivo studies in rats, Anesthesiology, 105, 801, 10.1097/00000542-200610000-00027 Luger, 2002, Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain, Pain, 99, 397, 10.1016/S0304-3959(02)00102-1 Mao, 1992, Differential roles of NMDA and non‐NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy, Brain Res., 598, 271, 10.1016/0006-8993(92)90193-D Mao, 1995, Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain, Pain, 61, 353, 10.1016/0304-3959(95)00022-K Mao, 1995, Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy, Neurosci. Lett., 198, 75, 10.1016/0304-3940(95)11975-3 Max, 1990, Towards physiologically based treatment of patients with neuropathic pain, Pain, 42, 131, 10.1016/0304-3959(90)91156-D Mizoguchi, 2006, Possible involvement of dynorphin A‐(1–17) release via μ1‐opioid receptors in spinal antinociception by endomorphin‐2, J. Pharmacol. Exp. Ther., 317, 362, 10.1124/jpet.105.098293 Mizoguchi, 2007, Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino‐TAPA, Eur. J. Pharmacol., 560, 150, 10.1016/j.ejphar.2007.01.014 Moulin, 2005, Methadone in the management of intractable neuropathic noncancer pain, Can. J. Neurol. Sci., 32, 340, 10.1017/S0317167100004236 Narita, 2000, Up‐regulation of the TrkB receptor in mice injured by the partial ligation of the sciatic nerve, Eur. J. Pharmacol., 401, 187, 10.1016/S0014-2999(00)00449-0 Narita, 2004, Increased phosphorylated‐mu‐opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation, Neurosci. Lett., 354, 148, 10.1016/j.neulet.2003.09.077 Narita, 2007, Role of spinal voltage‐dependent calcium channel alpha 2 delta‐1 subunit in the expression of a neuropathic pain‐like state in mice, Life Sci., 80, 2015, 10.1016/j.lfs.2007.02.045 Narita, 2008, Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain‐like state in mice: Evidence for less sensitivity to morphine, Neuropsychopharmacology, 33, 1097, 10.1038/sj.npp.1301471 Nielsen, 2000, Incomplete, asymmetric, and route‐dependent cross‐tolerance between oxycodone and morphine in the Dark Agouti rat, J. Pharmacol. Exp. Ther., 295, 91 Nielsen, 2007, Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain, Pain, 132, 289, 10.1016/j.pain.2007.03.022 Ogawa, 2002, Synthesis and structure‐activity relationships of an orally available and long‐acting analgesic peptide, Nα‐amidino‐Tyr‐d‐Arg‐Phe‐MeβAla‐OH (ADAMB), J. Med. Chem., 45, 5081, 10.1021/jm010357t Okon, 2007, Ketamine: An introduction for the pain and palliative medicine physician, Pain Physician, 10, 493, 10.36076/ppj.2007/10/493 Okuse, 1997, Regulation of expression of the sensory neuron‐specific sodium channel SNS in inflammatory and neuropathic pain, Mol. Cell. Neurosci., 10, 196, 10.1006/mcne.1997.0657 Ossipov, 1995, Inhibition by spinal morphine of the tail‐fick response is attenuated in rats with nerve ligation injury, Neurosci. Lett., 199, 83, 10.1016/0304-3940(95)12026-Z Pollack, 1998, Gabapentin as a potential treatment for anxiety disorders, Am. J. Psychiatry, 155, 992, 10.1176/ajp.155.7.992 Porreca, 1998, Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury, Brain Res., 795, 197, 10.1016/S0006-8993(98)00292-3 Portenoy, 1990, The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions, Pain, 43, 273, 10.1016/0304-3959(90)90025-9 Przewlocka, 1999, Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats, Eur. J. Pharmacol., 367, 189, 10.1016/S0014-2999(98)00956-X Rashid, 2002, Nonopioid and neuropathy‐specific analgesic action of the nootropic drug nefiracetam in mice, J. Pharmacol. Exp. Ther., 303, 226, 10.1124/jpet.102.037952 Rhodin, 2006, Methadone treatment of chronic non‐malignant pain and opioid dependence‐a long‐term follow‐up, Eur. J. Pain, 10, 271, 10.1016/j.ejpain.2005.05.003 Roberts, 1997, Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats, Brain Res., 754, 147, 10.1016/S0006-8993(97)00062-0 Rose, 2002, Gabapentin: Pharmacology and its use in pain management, Anaesthesia, 57, 451, 10.1046/j.0003-2409.2001.02399.x Sakurada, 2001, Differential antinociceptive effects induced by intrathecally administered endomorphin‐1 and endomorphin‐2 in the mouse, Eur. J. Pharmacol., 427, 203, 10.1016/S0014-2999(01)01238-9 Scott, 2002, Actions of intrathecal omega‐conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat, Eur. J. Pharmacol., 451, 279, 10.1016/S0014-2999(02)02247-1 Shimoyama, 2002, A mouse model of neuropathic cancer pain, Pain, 99, 167, 10.1016/S0304-3959(02)00073-8 Shir, 1990, A‐fibers mediate mechanical hyperesthesia and allodynia and C‐fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats, Neurosci. Lett., 115, 62, 10.1016/0304-3940(90)90518-E Sindrup, 1999, Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action, Pain, 83, 389, 10.1016/S0304-3959(99)00154-2 Takasaki, 2000, Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain, Jpn. J. Pharmacol., 83, 319, 10.1016/S0021-5198(19)30567-0 Takasaki, 2000, Allodynia and hyperalgesia induced by herpes simplex virus type‐1 infection in mice, Pain, 86, 95, 10.1016/S0304-3959(00)00240-2 Taylor, 2004, The biology and pharmacology of calcium channel α2‐δ proteins, CNS Drug Rev., 10, 183, 10.1111/j.1527-3458.2004.tb00012.x Trujillo, 1991, Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK‐801, Science, 251, 85, 10.1126/science.1824728 Vanderah, 2000, Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance, J. Neurosci., 20, 7074, 10.1523/JNEUROSCI.20-18-07074.2000 Wang, 2001, Pronociceptive actions of dynorphin maintain chronic neuropathic pain, J. Neurosci., 21, 1779, 10.1523/JNEUROSCI.21-05-01779.2001 Watson, 1998, Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia, Neurology, 50, 1837, 10.1212/WNL.50.6.1837 Watson, 2003, Controlled‐release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy, Pain, 105, 71, 10.1016/S0304-3959(03)00160-X Wong, 1988, [3H]MK‐801 labels a site on the N‐methyl‐d‐aspartate receptor channel complex in rat brain membranes, J. Neurochem., 50, 274, 10.1111/j.1471-4159.1988.tb13260.x Yajima, 2003, Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice, Brain Res., 992, 288, 10.1016/j.brainres.2003.08.042 Yajima, 2005, Direct evidence for the involvement of brain‐derived neurotrophic factor in the development of a neuropathic pain‐like state in mice, J. Neurochem., 93, 584, 10.1111/j.1471-4159.2005.03045.x Yang, 2004, Peripheral nerve injury induces trans‐synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord, Eur. J. Neurosci., 19, 871, 10.1111/j.0953-816X.2004.03121.x Yarnitsky, 1998, Neuropathic pain: Between positive and negative ends, Pain Forum, 7, 241, 10.1016/S1082-3174(98)80011-1 Zhang, 2002, GCPII (NAALADase) inhibition prevents long‐term diabetic neuropathy in type 1 diabetic BB/Wor rats, J. Neurol. Sci., 194, 21, 10.1016/S0022-510X(01)00670-0 Zurek, 2001, Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats, Pain, 90, 57, 10.1016/S0304-3959(00)00386-9